Reduced Socs3 expression in adipose tissue protects female mice against obesity-Induced insulin resistance

Diabetologia

Volumn 55, Issue 11, 2012, Pages 3083-3093

  Palanivel, R ^a   Fullerton, M D ^a   Galic, S ^b   Honeyman, J ^b   Hewitt, K A ^b   Jorgensen, S B ^b,c   Steinberg, G R ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Adipocyte protein 2 (aP2 FABP4); AMPK; Glucose homeostasis; Immunometabolism; Inflammation; Insulin receptor substrate; Leptin; Macrophage; Suppressor of cytokine signalling (Socs 3); Tumour necrosis factor (TNF)

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; SOCS3 GENE;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; DIETARY FATS; ENERGY METABOLISM; FEMALE; GLUCOSE INTOLERANCE; INFLAMMATION; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; OXYGEN CONSUMPTION; PHOSPHORYLATION; SEX FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84867581547     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2665-3     Document Type: Article

References (50)

1. Wormald S, Hilton DJ (2004) Inhibitors of cytokine signal transduction. J Biol Chem 279:821-824
2. Mori H, Hanada R, Hanada T et al (2004) Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to dietinduced obesity. Nat Med 10:739-743
3. Myers MG Jr (2004) Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res 59:287-304
4. Ueki K, Kondo T, Kahn CR (2004) Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 24:5434-5446
5. Steinberg GR, Smith AC, Wormald S, Malenfant P, Collier C, Dyck DJ (2004) Endurance training partially reverses dietaryinduced leptin resistance in rodent skeletal muscle. Am J Physiol Endocrinol Metab 286:E57-E63
6. Steinberg GR, McAinch AJ, Chen MB et al (2006) The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab 91:3592-3597
7. Emanuelli B, Peraldi P, Filloux C et al (2001) SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem 276:47944-47949
8. Wang Z, Zhou YT, Kakuma T et al (2000) Leptin resistance of adipocytes in obesity: Role of suppressors of cytokine signaling. Biochem Biophys Res Commun 277:20-26
9. Ghanim H, Aljada A, Daoud N, Deopurkar R, Chaudhuri A, Dandona P (2007) Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia 50:278-285
10. Ghanim H, Abuaysheh S, Sia CL et al (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: Implications for insulin resistance. Diabetes Care 32:2281-2287
11. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, van Obberghen E (2000) SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 275:15985-15991
12. Senn JJ, Klover PJ, Nowak IA et al (2003) Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 278:13740-13746
13. Rui L, Yuan M, Frantz D, Shoelson S, White MF (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitinmediated degradation of IRS1 and IRS2. J Biol Chem 277:42394-42398
14. Shi H, Tzameli I, Bjorbaek C, Flier JS (2004) Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem 279:34733-34740
15. Bjorbaek C, Lavery HJ, Bates SH et al (2000) SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem 275:40649-40657
16. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS (1999) The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 274:30059-30065
17. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C, Flier JS (2004) Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 10:734-738
18. Reed AS, Unger EK, Olofsson LE, Piper ML, Myers MG Jr, Xu AW (2010) Functional role of suppressor of cytokine signaling 3 upregulation in hypothalamic leptin resistance and long-term energy homeostasis. Diabetes 59:894-906
19. Bjornholm M, Munzberg H, Leshan RL et al (2007) Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. J Clin Invest 117:1354-1360
20. Wang MY, Orci L, Ravazzola M, Unger RH (2005) Fat storage in adipocytes requires inactivation of leptin's paracrine activity: Implications for treatment of human obesity. Proc Natl Acad Sci U S A 102:18011-18016
21. Wang MY, Lee Y, Unger RH (1999) Novel form of lipolysis induced by leptin. J Biol Chem 274:17541-17544
22. Orci L, Cook WS, Ravazzola M et al (2004) Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci U S A 101:2058-2063
23. Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB (2010) Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: Role of ATGL, HSL, and AMPK. Am J Physiol Cell Physiol 298:C961-C971
24. Gauthier MS, O'Brien EL, Bigornia S et al (2010) Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem Biophys Res Commun 404:382-387
25. Krebs DL, Hilton DJ (2001) SOCS proteins: Negative regulators of cytokine signaling. Stem Cells 19:378-387
26. Shi H, Cave B, Inouye K, Bjorbaek C, Flier JS (2006) Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 55:699-707
27. Jamieson E, Chong MM, Steinberg GR et al (2005) Socs1 deficiency enhances hepatic insulin signaling. J Biol Chem 280:31516-31521
28. Torisu T, Sato N, Yoshiga D et al (2007) The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes Cells 12:143-154
29. Sachithanandan N, Fam BC, Fynch S et al (2010) Liver specific SOCS3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. Hepatology 52:1632-1642
30. Kiu H, Greenhalgh CJ, Thaus A et al (2009) Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2. Growth Factors 27:384-393
31. Abel ED, Peroni O, Kim JK et al (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729-733
32. Galic S, Fullerton MD, Schertzer JD et al (2011) Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest 121:4903-4915
33. O'Neill HM, Maarbjerg SJ, Crane JD et al (2011) AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci U S A 108:16092-16097
34. Dzamko N, Vandenderen BJ, Hevener AL et al (2010) AMPK ß1 deletion reduces appetite preventing obesity and hepatic insulin resistance. J Biol Chem 285:115-122
35. Saab C, Labiris N, Chirakal R, Farncombe T (2007) A database of normal PET and SPECT radiotracer distributions in rats and mice. J Nucl Med Meeting Abstracts 48:292P-b-36
36. Watt MJ, Dzamko N, Thomas WG et al (2006) CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med 12:541-548
37. Chen Z-P, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE (2000) AMPK signaling in contracting human skeletal muscle: Acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol 279:E1202-E1206
38. Maeda K, Cao H, Kono K et al (2005) Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 1:107-119
39. Jiang C, Qu A, Matsubara T et al (2011) Disruption of hypoxiainducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fedmice. Diabetes 60:2484-2495
40. Wueest S, Rapold RA, Schumann DM et al (2010) Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J Clin Invest 120:191-202
41. Kumar A, Lawrence JC Jr, Jung DY et al (2010) Fat cell-specific ablation of rictor inmice impairs insulin-regulated fat cell and wholebody glucose and lipid metabolism. Diabetes 59:1397-1406
42. Hirosumi J, Tuncman G, Chang L et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333-336
43. Gao Z, Hwang D, Bataille F et al (2002) Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277:48115-48121
44. Croker BA, Krebs DL, Zhang JG et al (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4:540-545
45. Galic S, Oakhill JS, Steinberg GR (2010) Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316:129-139
46. Bence KK, Delibegovic M, Xue B et al (2006) Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 12:917-924
47. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025
48. Arnold SF, Obourn JD, Jaffe H, Notides AC (1995) Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol Endocrinol 9:24-33
49. Leong GM, Moverare S, Brce J et al (2004) Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and-3 in vivo and in vitro. Endocrinology 145:5525-5531
50. Ribas V, Nguyen MT, Henstridge DC et al (2010) Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab 298:E304-E319